skip to Main Content

Welcome

Celebrating 80 Years Of Service!

The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.

"Advance the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery through training, education, and advocacy."

ADVOCACY UPDATES

Medicare 2022 Conversion Factor Update

Thanks to lobbying efforts from the House of Medicine, Congress took action this month. The…

Read more

CY 2022 Physician Fee Schedule Proposed Rule Summary

On July 13, the Centers for Medicare & Medicaid Services (CMS) released the Medicare Physician…

Read more

Congress Considers Extension of Telehealth Flexibilities Post-Pandemic

The COVID-19 pandemic forced Congress and the Centers for Medicare & Medicaid Services (CMS) to…

Read more

Changes in MACRA

Macra 101 Image

Before the close of 2017, all physicians must take action to avoid the 4 percent cut that will be assessed in 2019 for not participating in the new Quality Payment Program (QPP) authorized by the Medicare Access and CHIP Reauthorization Act (MACRA).  Read More

CMS Announces Changes in MACRA Implementation Timeline. The Centers for Medicare and Medicaid Services (CMS) announced major changes to the implementation of the Medicare Access and CHIP Re-authorization (MACRA).
Read More

Upcoming Dates

07/28/22: Membership Application Deadline to be voted in at the 2022 Annual Meeting

12/01/22: Research Grant Cycle
Learn more

04/01/23: Fellow Exam Application Deadline
Learn more

06/01/23: Research Grant Cycle
Learn more

06/26/23: Membership Application Deadline to be eligible for AAOA Member rate for the 2023 Basic Course

07/01/23: Scientific Abstract Submission Deadline
Learn more

EDUCATION

Join us at the 2022 AAOA Hybrid Annual Meeting! We are excited to bring back our ever-popular Content Meets Culture Tours, Research Forum, Wait, Wait Do Tell Me, Shark Tank, and more. New this year! Amazing Case Race scavenger hunt, Pardon the Interruption debates on biologics, SLIT/SCIT, Sinus Surgery, and more, Biologics Dating Game, and Post-COVID Pearls and Tips on the business side of comprehensive ENT, including discussion around the impact of independent scope of practice, site of service options for procedures, building staff culture to retain staff, and more "ah-ha's" to take home. Register Now

RESIDENTS

For information about Resident opportunities, DosedDaily, research grants, and other resources. Learn More

IFAR

Available Now

aaoaf-ifar

IFAR Impact Factor: 2.454

IFAR Featured Content: COVID-19 - Free Access
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies . Read More

Changes in Managing Practices

Working together with AAOA staff, volunteer leadership and members will enable us to have a positive impact on our members’ practices.

Read More

Live and Online CME

2022 AAOA Basic Course - Hybrid!
The Diplomat Beach Resort, Hollywood, FL
On-demand Access Until September 2, 2022
Learn More and Register
On-Demand and Live Stream Access

2022 AAOA Annual Meeting
Loews Philadelphia, PA
September 9-11, 2022- F2F - Live Stream
Learn More and Register

2023 AAOA Advanced Course in Allergy & Immunology
March 30 - April 1, 2023
The Hythe Vail
Formerly the Vail Marriott Mountain Resort

USP 797 Online Module
Learn More and Register

News and Updates

Helping Private Practices Navigate Non-Essential Care During COVID-19

The American Medical Association has released updated guidance for private practice physicians navigating the provision…

Read more

Office Hours With AAOA President

As you know, AAOA is about its members and our community. In an effort to…

Read more
College Allergy Symptoms Treatment Back to Shcool

PRACTICE RESOURCES

AAOA Practice Resource Tool Kit

The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.

Read More

PARTNER RESOURCE CENTER

AAOA has launched a Partner Resource Center to bring you partner resources that can assist your practice and patient care.

Visit the New Center>

PATIENT CORNER

Fall Advocacy Update: USP 797, E/M Documentation and Payment

Revisions to USP Chapter 797 Open for Comment

Since the United States Pharmacopeia (USP) released a proposed update to Chapter 797 in 2015, AAOA has been working with other concerned organizations including the American Academy of Allergy, Asthma & Immunology, the American College of Allergy, Asthma, and Immunology, and the American Medical Association, to ensure that the chapter does not limit members’ ability to compound allergen immunotherapy extracts in their offices, limiting patient access.

The initial proposal treated all sterile compounds, including allergen extracts, as equally and inherently dangerous. In response, AAOA, as well as AAAAI and ACAAI, submitted comments to USP about the negative impact finalizing this proposal would have on patient access and the cost of this therapy.   The Academy also participated in multiple roundtables with the USP and Food and Drug Administration (FDA) to prevent the initial proposal from being finalized.

This summer USP released a significantly revised Chapter 797. AAOA’s advocacy was a success. In this revision, the compounding of allergen extracts was restored as a separate section of the chapter, and the proposed revisions are aligned with current FDA guidance. The chapter articulates requirements for personnel training and evaluation, hygiene and garbing, and updated documentation requirements. There are specific requirements for the compounding surface and surrounding area. Notably, the controversial requirement that a hood be in place for compounding allergen extracts has been removed.

USP is accepting comments on the proposed Chapter 797 until November 30. The final chapter is expected to be released June 1, 2019 and to take effect on December 1, 2019. AAOA encourages members to comment in support of these revisions.

CMS Considering Changes to E/M Documentation and Payment

In the proposed CY 2019 Physician Fee Schedule (PFS), the Centers for Medicare and Medicaid Services (CMS) included a proposal to change how evaluation and management (E/M) services are documented and billed. The agency’s goal is to reduce the administrative burden of the documentation requirements on physicians.

Rather than requiring physicians to use the 1995/1997 guidelines, they would only be required to document a level 2 visit for new and established patients using either time, medical decision making, or the current guidelines under the proposal. CMS also proposed creating single payment levels for level 2-5 office visits for new and established patients to address the auditing concerns raised by the documentation proposal. They also proposed creating a primary care and complexity add-on code, the latter can be billed for allergy services, to address potential decreases in payment. Other payment proposals included a prolonged E/M service for an additional 30 minutes of time spent with the patient and applying a multiple procedure payment adjuster when certain procedures are billed with E/M visits.

One of the unintended consequences of this proposal was a proposed decrease in practice expense (PE) for certain allergy services. CMS created a new PE category for the single payment level E/M services, and this adversely impacted the indirect PE for allergy and other specialties. This change is of great concern to AAOA.

The physician community united in opposition to this proposal and urged CMS to implement certain documentation changes that could be implemented separately from the E/M payment changes and work with stakeholders to develop an alternative payment proposal. The American Medical Association has convened a joint CPT-RUC workgroup to develop an alternative coding proposal in response.

CMS is expected to release the final PFS rule on or around November 1 and only then will we know what policy will be finalized. It is unlikely that the agency will implement the policy as proposed, but it is hard to know how significantly it will be changed. AAOA will update members once a final policy is released and inform you how it will impact your practice.

Back To Top